Our COST Action will bring together excellent researchers from Europe to contribute a broad spectrum of scientific expertise, cutting-edge technologies, scientific exchange and education to foster breakthrough science that moves the field forward towards improving the treatment of patients with heart failure.
Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality in Europe, often leading to heart failure (HF), the largest disease burden in Europe. 
Objectives: Facilitate an interdisciplinary dialogue, knowledge and technology transfer to improve our understanding of metabolic alterations in heart failure. 

EU-METAHEART COST Action

Org chart

Teams

Offices

EU-METAHEART COST Action

Org chart

Teams

Offices

Related companies